Qube Research & Technologies (QRT)
PALI icon

Qube Research & Technologies (QRT)’s Palisade Bio PALI Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio PALI Stock Details PALI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-148,970
Closed -$261K – 3910
2026
Q1 		$261K Buy
+148,970
New +$271K ﹤0.01% 2899

Other funds holding PALI

SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
BGI
B Group Inc Dallas, Texas $213M AUM 96.05% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $1.11B AUM 866.76% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Qube Research & Technologies (QRT)'s PALI Position: Q2 2026 in Review

Qube Research & Technologies (QRT) sold out of Palisade Bio (PALI) in Q2 2026, closing a stake of 148,970 shares — an estimated $261K sold.

Qube Research & Technologies (QRT) first reported a position in PALI in Q1 2026 and held it in 1 quarter. The position peaked at $261K in Q1 2026. 124 funds tracked by Wall St. Rank hold PALI as of Q2 2026.

  • Qube Research & Technologies (QRT) reported no remaining Palisade Bio position as of Q2 2026 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 148,970 Palisade Bio shares in Q2 2026, an estimated $261K.
  • Qube Research & Technologies (QRT) first reported a position in Palisade Bio in Q1 2026 and held it in 1 quarter.
  • Qube Research & Technologies (QRT)'s Palisade Bio position peaked at $261K in Q1 2026.
  • 124 funds tracked by Wall St. Rank held Palisade Bio as of Q2 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q2 2026, filed 14 Aug 2026.